Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1948 3
1950 5
1952 2
1953 7
1954 6
1955 7
1956 9
1957 7
1958 6
1959 15
1960 9
1961 17
1962 20
1963 15
1964 13
1965 10
1966 11
1967 17
1968 13
1969 14
1970 12
1971 16
1972 11
1973 18
1974 13
1975 20
1976 25
1977 26
1978 36
1979 28
1980 41
1981 53
1982 65
1983 76
1984 79
1985 75
1986 82
1987 85
1988 107
1989 139
1990 116
1991 153
1992 167
1993 116
1994 161
1995 143
1996 169
1997 165
1998 179
1999 187
2000 178
2001 199
2002 196
2003 190
2004 260
2005 292
2006 301
2007 324
2008 356
2009 377
2010 391
2011 447
2012 479
2013 499
2014 491
2015 493
2016 564
2017 539
2018 605
2019 561
2020 688
2021 713
2022 661
2023 584
2024 414

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,493 results

Results by year

Filters applied: . Clear all
Page 1
Malignant pleural mesothelioma: recent developments.
Sinn K, Mosleh B, Hoda MA. Sinn K, et al. Curr Opin Oncol. 2021 Jan;33(1):80-86. doi: 10.1097/CCO.0000000000000697. Curr Opin Oncol. 2021. PMID: 33186182 Review.
PURPOSE OF REVIEW: Malignant pleural mesothelioma (MPM) is a rare, but aggressive tumor with still poor prognosis. ...
PURPOSE OF REVIEW: Malignant pleural mesothelioma (MPM) is a rare, but aggressive tumor with still poor prognosis. ...
New Era for Malignant Pleural Mesothelioma: Updates on Therapeutic Options.
Tsao AS, Pass HI, Rimner A, Mansfield AS. Tsao AS, et al. J Clin Oncol. 2022 Feb 20;40(6):681-692. doi: 10.1200/JCO.21.01567. Epub 2022 Jan 5. J Clin Oncol. 2022. PMID: 34985934 Free PMC article. Review.
Malignant pleural mesothelioma (MPM) is a rare malignancy with few treatment options. Recent advances have led to US Food and Drug Administration approvals and changes in the standard of care with a novel biomedical device approved for use with platinum-pemetrexed,
Malignant pleural mesothelioma (MPM) is a rare malignancy with few treatment options. Recent advances have led to US Food and
The Molecular Basis of Malignant Pleural Mesothelioma.
Wadowski B, De Rienzo A, Bueno R. Wadowski B, et al. Thorac Surg Clin. 2020 Nov;30(4):383-393. doi: 10.1016/j.thorsurg.2020.08.005. Epub 2020 Sep 12. Thorac Surg Clin. 2020. PMID: 33012428 Free PMC article. Review.
Malignant pleural mesothelioma (MPM) is a rare, aggressive malignancy of the pleural lining associated with asbestos exposure in greater than 80% of cases. ...
Malignant pleural mesothelioma (MPM) is a rare, aggressive malignancy of the pleural lining associated with asbestos exposure
Pleural mesothelioma classification-update and challenges.
Dacic S. Dacic S. Mod Pathol. 2022 Jan;35(Suppl 1):51-56. doi: 10.1038/s41379-021-00895-7. Epub 2021 Aug 31. Mod Pathol. 2022. PMID: 34465883 Free article. Review.
The benign or preinvasive group includes adenomatoid tumors, well-differentiated papillary mesothelial tumors, and mesothelioma in situ. Malignant tumors are mesotheliomas and can be localized or diffuse. ...The use of these two biomarkers improves the diagnostic se …
The benign or preinvasive group includes adenomatoid tumors, well-differentiated papillary mesothelial tumors, and mesothelioma in si …
Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma.
Wang Q, Xu C, Wang W, Zhang Y, Li Z, Song Z, Wang J, Yu J, Liu J, Zhang S, Cai X, Li W, Zhan P, Liu H, Lv T, Miao L, Min L, Li J, Liu B, Yuan J, Jiang Z, Lin G, Chen X, Pu X, Rao C, Lv D, Yu Z, Li X, Tang C, Zhou C, Zhang J, Guo H, Chu Q, Meng R, Liu X, Wu J, Hu X, Zhou J, Zhu Z, Chen X, Pan W, Pang F, Zhang W, Jian Q, Wang K, Wang L, Zhu Y, Yang G, Lin X, Cai J, Feng H, Wang L, Du Y, Yao W, Shi X, Niu X, Yuan D, Yao Y, Huang J, Wang X, Zhang Y, Sun P, Wang H, Ye M, Wang D, Wang Z, Hao Y, Wang Z, Wan B, Lv D, Yu J, Kang J, Zhang J, Zhang C, Wu L, Shi L, Ye L, Wang G, Wang Y, Gao F, Huang J, Wang G, Wei J, Huang L, Li B, Zhang Z, Li Z, Liu Y, Li Y, Liu Z, Yang N, Wu L, Wang Q, Huang W, Hong Z, Wang G, Qu F, Fang M, Fang Y, Zhu X, Du K, Ji J, Shen Y, Chen J, Zhang Y, Ma S, Lu Y, Song Y, Liu A, Zhong W, Fang W. Wang Q, et al. Thorac Cancer. 2023 Sep;14(26):2715-2731. doi: 10.1111/1759-7714.15022. Epub 2023 Jul 17. Thorac Cancer. 2023. PMID: 37461124 Free PMC article.
Malignant pleural mesothelioma (MPM) is a malignant tumor originating from the pleura, and its incidence has been increasing in recent years. ...Immunotherapy and electric field therapy have also been applied, leading to further improvements in patient surviv
Malignant pleural mesothelioma (MPM) is a malignant tumor originating from the pleura, and its incidence has been incre
The Staging of Malignant Pleural Mesothelioma.
Euhus CJ, Ripley RT. Euhus CJ, et al. Thorac Surg Clin. 2020 Nov;30(4):425-433. doi: 10.1016/j.thorsurg.2020.07.001. Epub 2020 Sep 12. Thorac Surg Clin. 2020. PMID: 33012430 Review.
Staging of malignant pleural mesothelioma has been challenging because of a paucity of cases and poor survival. ...
Staging of malignant pleural mesothelioma has been challenging because of a paucity of cases and poor survival. ...
Radiation Therapy for Malignant Pleural Mesothelioma.
Rosenzweig KE. Rosenzweig KE. Thorac Surg Clin. 2020 Nov;30(4):473-480. doi: 10.1016/j.thorsurg.2020.08.006. Epub 2020 Sep 12. Thorac Surg Clin. 2020. PMID: 33012434 Review.
The treatment of malignant pleural mesothelioma with radiation therapy has always been a technical challenge. ...
The treatment of malignant pleural mesothelioma with radiation therapy has always been a technical challenge. ...
Clinical presentation, treatment and outcome of canine malignant mesothelioma: A retrospective study of 34 cases.
Moberg HL, Gramer I, Schofield I, Blackwood L, Killick D, Priestnall SL, Guillén A. Moberg HL, et al. Vet Comp Oncol. 2022 Mar;20(1):304-312. doi: 10.1111/vco.12777. Epub 2021 Oct 25. Vet Comp Oncol. 2022. PMID: 34647420
Canine malignant mesothelioma (CMM) is a rare and aggressive tumour associated with a poor prognosis. ...Further studies are needed to determine the optimal treatment approach for malignant mesothelioma in dogs. Nevertheless, effusion recurrence should …
Canine malignant mesothelioma (CMM) is a rare and aggressive tumour associated with a poor prognosis. ...Further studies are n …
Pleural mesothelioma classification update.
Beasley MB, Galateau-Salle F, Dacic S. Beasley MB, et al. Virchows Arch. 2021 Jan;478(1):59-72. doi: 10.1007/s00428-021-03031-7. Epub 2021 Jan 21. Virchows Arch. 2021. PMID: 33475835 Review.
Because of tumor rarity and overlapping histologic features with other tumor types, diagnostic immunohistochemical work up is essential component in establishing the final diagnosis of mesothelioma. The use of BAP1 and CDKN2A/MTAP improves the diagnostic sensitivity of eff …
Because of tumor rarity and overlapping histologic features with other tumor types, diagnostic immunohistochemical work up is essential comp …
12,493 results
You have reached the last available page of results. Please see the User Guide for more information.